This review is the summary of a workshop on small airways disease, which took place in
Porquerolles, France in November 2011. The purpose of this workshop was to review the …

Immune checkpoint inhibitors (ICIs) are antibodies that target key signalling pathways such
as programmed death 1 (PD1)/programmed death-ligands 1 and 2 (PDL1 and PDL2) to …

Background Shortening the duration of antibiotic therapy for patients admitted to hospital
with community-acquired pneumonia should help reduce antibiotic consumption and thus …

Interventional radiologists should be familiar with minimally invasive procedures used to treat
various abnormalities of the pulmonary arteries. These well-established techniques, which …

Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder characterized by epistaxis,
telangiectasia, and visceral vascular manifestations. Infectious and ischemic central …

Immune checkpoint inhibitors, as nivolumab, are used in advanced non-small cell lung cancer
(NSCLC). However, no associated biomarker is validated in clinical practice with this drug…

The severity and type of clinical manifestations are variable in patients with cystic fibrosis (CF).
The respiratory syndromes in these patients consist of lung infections associated with …

Idiopathic interstitial pneumonias (IIPs) comprise a heterogeneous group of rare lung
parenchyma disorders with high morbidity and mortality, which can occur at all ages. In adults, the …

We report the case of a cystic fibrosis patient colonized with a smooth-morphotype form of
Mycobacterium abscessus who developed acute respiratory failure with the emergence of an …

Little is known about longitudinal lung function variation in patients with pulmonary Langerhans’
cell histiocytosis (LCH). The contribution of serial lung computed tomography (CT) to …